title: Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02215.
authors.forename: P M
authors.initials: PM
authors.lastname: Ridker
authors.forename: P R
authors.initials: PR
authors.lastname: Hebert
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: C H
authors.initials: CH
authors.lastname: Hennekens
mesh_terms: D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D015912:Thrombolytic Therapy
chemical_list: D006493:Heparin; D001241:Aspirin